Improving Antibiotic use to treat tuberculosis
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Improving Antibiotic use to treat tuberculosis
  • Published Date:

    1/4/18

  • Language:
    English
Filetype[PDF-256.60 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.03 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    4/4/17
    Description:
    The purpose of this toolkit is to assist TB programs in developing and implementing a TB eDOT program. There are a wide variety of eDOT programs throughout the United States. These eDOT programs have been designed to meet their respective TB programâ...
    File Type:
    Filetype[PDF - 1.03 MB]
  2. Filetype[PDF - 1.46 MB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). American Thoracic Society.. Infectious Diseases Society of America..
    Published Date:
    June 20, 2003
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2003; 52(RR-11):1-77.
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-11
    American journal of respiratory and critical care medicine ; v. 167, p. 603-662
    Description:
    The recommendations in this document are intended to guide the treatment of tuberculosis in settings where mycobacterial cultures, drug susceptibility testing, radiographic facilities, and second-line drugs are routinely available. In areas where the...
    File Type:
    Filetype[PDF - 1.46 MB]
  3. Filetype[PDF - 507.25 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    10/9/12
    File Type:
    Filetype[PDF - 507.25 KB]
  4. Filetype[PDF - 195.72 KB]
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    November 2011
    Source:
    TB elimination
    Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminating TB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. Certain groups are at very high risk ...
    File Type:
    Filetype[PDF - 195.72 KB]
  5. Filetype[PDF - 1.30 MB]
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published Date:
    August 2016
    Series:
    TB elimination
    Description:
    Treatment of latent tuberculosis (TB) infection (LTBI) is essential to controlling and eliminatingTB in the United States, because it substantially reduces the risk that TB infection will progress to TB disease. The Centers for Disease Control and Pr...
    File Type:
    Filetype[PDF - 1.30 MB]